Dimitra-Maria Koukou

Dr. Dimitra-Maria Koukou


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
VSVana Spoulou
Vana Spoulou
MNMaria Noni
Maria Noni
DKDimitra-Maria Koukou
Dimitra-Maria Koukou
AKAthanasios Kossyvakis
Athanasios Kossyvakis
Athanasios MichosAthanasios Michos
Athanasios Michos


2 May 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
DKDimitra-Maria Koukou
Dimitra-Maria Koukou
CDCharilaos Dellis
Charilaos Dellis
MDMaria-Myrto Maria-Myrto Dourdouna
Maria-Myrto Maria-Myrto Dourdouna
VEVasiliki Efthymiou
Vasiliki Efthymiou
VSVasiliki Syriopoulou
Vasiliki Syriopoulou
Rotavirus group A (RVA) is characterized by molecular and epidemiological diversity. To date, 42 G and 58 P RVA genotypes have been identified, some of which, like P[14], have a zoonotic origin. In this study, we describe the epidemiology of unusual RVA genotypes and the molecular characteristics of P[14] strains. Fecal samples from children ≤ 16 years of age with acute gastroenteritis (AGE) who were hospitalized during 2007–2021 in Greece were tested for RVA by immunochromatography. Positive RVA samples were G and P genotyped, and part of the VP7 and VP4 genes were sequenced by the Sanger method. Epidemiological data were also recorded. Phylogenetic analysis of P[14] was performed using MEGA 11 software. Sixty-two (1.4%) out of 4427 children with RVA AGE were infected with an unusual G (G6/G8/G10) or P (P[6]/P[9]/P[10]/P[11]/P[14]) genotype. Their median (IQR) age was 18.7 (37.3) months, and 67.7% (42/62) were males. None of the children were vaccinated against RVA. P[9] (28/62; 45.2%) was the most common unusual genotype, followed by P[14] (12/62; 19.4%). In the last two years, during the period of the COVID-19 pandemic, an emergence of P[14] was observed (5/12, 41.6%) after an 8-year absence. The highest prevalence of P[14] infection was seen in the spring (91.7%). The combinations G8P[14] (41.7%), G6P[14] (41.7%), and G4P[14] (16.6%) were also detected. Phylogenetic analysis showed a potential evolutionary relationship of three human RVA P[14] strains to a fox strain from Croatia. These findings suggest a possible zoonotic origin of P[14] and interspecies transmission between nondomestic animals and humans, which may lead to new RVA genotypes with unknown severity.

24 November 2022 in Eurosurveillance
Verified
Journal Article
Open access
DKDimitra-Maria Koukou
Dimitra-Maria Koukou
Athanasios MichosAthanasios Michos
Athanasios Michos
PCPanagiota Chatzichristou
Panagiota Chatzichristou
GTGeorgios Trimis
Georgios Trimis
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
OGon behalf of Greek Rotavirus Study Group
on behalf of Greek Rotavirus Study Group
Background: Two rotavirus (RV) vaccines were licensed in Greece in late 2006 and included in the national immunisation programme in 2012. Aim: To study the epidemiology and genotype distribution of RV in children during the post-vaccination period and assess the impact of increased vaccination coverage. Methods: In a prospective multicentre hospital-based study, hospitalised children (≤ 16 years) with an RV-positive faecal sample were recruited. Epidemiological and genotyping analyses were performed; periods of low (2008–12) and moderate (2012–20) RV vaccination coverage were compared. Statistical analysis was performed with a chi-squared or Mann–Whitney U test and logistic regression. Results: A total of 3,874 children (55.6% male; n = 2,153) with median age of 1.4 years (IQR: 0.5–3.3) were studied during 2008–20. Most RV-infected children were aged ≤ 3 years (72.2%) and hospitalised during December–May (69.1%). Common RV genotypes (G1P[8], G2P[4], G3P[8], G4P[8], G9P[8], G12P[8]) were detected in 92.2% of samples; G-P combinations with prevalence above 1% were G4P[8] (44.1%), G1P[8] (25.4%), G2P[4] (14.9%), G9P[8] (3.5%), G12P[8] (2.2%), G3P[8] (2.1%), other (4.3%) and mixed (3.5%). Of all samples, 97.6% were homotypic or partially heterotypic to vaccines’ genotypes. With moderate vaccination coverage, the seasonal peak was detected earlier, children were older and partially or fully heterotypic genotypes were increased (p < 0.001). Conclusions: In the era of moderate RV vaccination coverage in Greece, epidemiology of RV in hospitalised children seemed to change. However, most circulating genotypes remain homotypic or partially heterotypic to RV vaccines. Continuous epidemiological surveillance and genotyping are important to monitor possible changes arising from RV vaccines’ implementation.


1 January 2024 in Advances in Virology
Verified
Journal Article
Open access
CDCharilaos Dellis
Charilaos Dellis
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
DKDimitra-Maria Koukou
Dimitra-Maria Koukou
Filippos FilippatosFilippos Filippatos
Filippos Filippatos
EVEvangelia-Eirini Vetouli
Evangelia-Eirini Vetouli
VSVasiliki Syriopoulou
Vasiliki Syriopoulou
Group A rotavirus (RVA), which causes acute gastroenteritis (AGE) in children worldwide, is categorized mainly based on VP7 (genotype G) and VP4 (genotype P) genes. Genotypes that circulate at <1% are considered unusual. Important genes also include VP6 (genotype I) and NSP4 (genotype E). VP6 establishes the group and affects immunogenicity, while NSP4, as an enterotoxin, is responsible for the clinical symptoms. The aim of this study was to genotype the VP6 and NSP4 genes and molecularly characterize the NSP4 and VP6 genes of unusual RVA. Unusual RVA strains extracted from fecal samples of children ≤16 years with AGE were genotyped in VP6 and NSP4 genes with Sanger sequencing. In a 15‐year period (2007–2021), 54.8% (34/62) of unusual RVA were successfully I and E genotyped. Three different I and E genotypes were identified; I2 (73.5%, 25/34) and E2 (35.3%, 12/34) were the most common. E3 genotype was detected from 2017 onwards. The uncommon combination of I2‐E3 was found in 26.5% (9/34) of the strains and G3‐P[9]‐I2‐E3 remained the most frequent G‐P‐I‐E combination (20.6%, 7/34). Children infected with RVA E2 strains had a statistically higher frequency of dehydration (50%) than those infected with RVA E3 strains (p = 0.019). Multiple substitutions were detected in NSP4, but their functional effect remains unknown. The result indicates the genetic diversity of RVA strains. Continuous surveillance of the RVA based on the whole genome will provide better knowledge of its evolution.